Quick Takeaways
- Theodore R. Schroeder has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $113,561.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Theodore R. Schroeder and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| PHAT | Phathom Pharmaceuticals, Inc. | Director | $95,577 | 16 Apr 2025 | ||
| NBRV | Nabriva Therapeutics plc | Director | $17,984 | 29 Jan 2023 | ||
| CDTX | Cidara Therapeutics, Inc. | Director | 07 Jan 2026 | |||
| OTIC | OTONOMY, INC. | Director | 21 Jun 2022 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|